• 1 January 1982
    • journal article
    • research article
    • Vol. 50  (2) , 434-441
Abstract
Human leukocyte dialysates contain components which, when injected intradermally in combination with an antigen to which the recipient displays prior sensitivity, produces an accelerated and intensified delayed hypersensitivity response. These components which were termed leukocyte amplifiers, can be partially purified by gel filtration on Sephadex G-10 followed by high pressure reverse phase chromatography. The amplifiers do not produce an inflammatory reaction when injected intradermally by themselves. Amplifying effects were not observed when analogous sub-fractions prepared from erythrocytes or platelets were employed in the same manner. The leukocyte amplifiers were not able to transfer a new sensitivity to a non-sensitive recipient.